Oshima Yukiko, Watanabe Takanori, Nakagawa Saki, Endo Ayako, Shiga Chizuko
Dept. of Surgery, Sendai Medical Center.
Gan To Kagaku Ryoho. 2012 Sep;39(9):1375-8.
Hair loss is one of the most common side effects of chemotherapies such as FEC and taxane, and it greatly affects quality of life. We conducted a questionnaire survey of breast cancer patients who were treated with adjuvant chemotherapy about their hair loss. Eighty-five patients participated. They all had lost their hair and suffered from persistent changes in their hair condition, ranging from thinning to curly. More than 80% of patients had worn wigs until their hair had grown back. Furthermore, a few patients did not remove their wigs for 2 years after treatment. Unfortunately, there is no prevention or medication to combat hair loss due to chemotherapy at present, so cumulative examinations are awaited. We must provide appropriate information and support to the patient.
脱发是FEC和紫杉烷等化疗最常见的副作用之一，它极大地影响生活质量。我们对接受辅助化疗的乳腺癌患者进行了关于脱发的问卷调查。85名患者参与了调查。他们都出现了脱发，并且头发状况持续改变，从变稀到卷曲不一。超过80%的患者在头发重新长出来之前一直戴着假发。此外，有少数患者在治疗后两年都没有摘下假发。遗憾的是，目前尚无预防或对抗化疗引起脱发的药物，因此期待进行累积研究。我们必须为患者提供适当的信息和支持。
